RecruitingNot ApplicableNCT07283653

Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial


Sponsor

M.D. Anderson Cancer Center

Enrollment

85 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • A hospital or clinic affiliated with the Veteran's Affairs system, University of Wisconsin system, or Ohio State University system.
  • A minimum average of 10 Modified Barium Swallow (MBS) procedures per month in oncology patients in preceding year.
  • MBS imaging files are recorded and archived as a routine procedure (and accessible to researchers).

Exclusion Criteria1

  • N/A

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

receive no active implementation

OTHERDIGEST Training Program

Investigator led training program

OTHERDIGEST Training + Practice Facilitation

Training plus practice facilitation


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07283653


Related Trials